UNSPSC 51293900: Antidepressant methylamines

Antidepressant drugs made from amines and ammonia derivatives based on CH3NH2.

UNSPSC 51293900 Antidepressant methylamines (Class) shows minimal alignment between the code's nominal scope and recent state and local procurement activity. The three most recent opportunities posted under or near this code involve naloxone distribution, direct-to-manufacturer pharmacy programs, and generic multi-source pharmaceuticals and OTC products—none of which are antidepressant medications or methylamine compounds. State and local procurement offices appear to use this code inconsistently or as a catch-all for pharmaceutical procurement, rather than for its stated therapeutic category. The issuing bodies span county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), and multistate cooperative purchasing alliances (Minnesota MMCAP serving state and local participants across multiple states including Oregon).

Recent opportunities show pharmaceutical supply chains, not antidepressant manufacture or specialty chemical compounds. Seminole County released IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a July 26, 2023, response deadline; Texas HHS issued RFI HHS0017013 on April 3, 2026, to explore direct-to-manufacturer prescription fulfillment models; and Minnesota MMCAP released an RFP for generic multi-source pharmaceuticals and OTC products on January 20, 2026, with responses due March 26, 2026. The code shows activity across Florida, Texas, Minnesota, and Oregon, but the mismatch between the code's stated purpose (antidepressant methylamines) and actual buying patterns (emergency response medications, pharmacy benefit management, and generic commodity pharmaceuticals) suggests either systematic miscoding by procurement offices or that this code is no longer actively used for its original intended commodity.